将拉尼比祖马布与二甲酸盐结合使用,以减少糖尿病黄斑的治疗中注射频率
Jian-Ying Chen1, Hong-Wei Pan1,2, Xiao-Ming Zhang3
1Department of Ophthalmology, The First Affiliated Hospital, Jinan University, Guangzhou, 510632, China.
International ophthalmology
|May 17, 2025
概括
结合二甲酸与拉尼比祖马布注射,降低了糖尿病黄斑 (DME) 的治疗频率. 这种组合疗法也比单独的拉尼比祖马布更有效地改善了视力敏度和减少斑点厚度.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病黄斑 (DME) 会导致视力损伤.
- 目前的治疗方法,如内拉尼比祖马布,需要经常注射.
- 在保持疗效的同时减少治疗频率是临床目标.
研究的目的:
- 评估二甲酸与静脉内拉尼比祖马布相结合是否可以降低DME患者的治疗频率.
- 评估这种组合治疗的临床结果,包括视力敏度和斑点厚度.
主要方法:
- 一项为期12个月的比较研究涉及90名DME患者.
- 一组 (45名患者) 接受了拉尼比祖马布注射和二酸盐囊.
- 对照组 (45名患者) 仅接受拉尼比祖马布注射,根据需要调整治疗.
主要成果:
- 组合治疗组所需的注射次数 (4.73) 比单一治疗组 (6.02) (p < 0.05) 的注射次数要少.
- 这两组在最佳校正视敏度 (BCVA) 和中央黄斑厚度 (CMT) (p <0.05) 中均显著改善.
- 组合治疗组在BCVA和CMT方面表现出更大的改善.
结论:
- 与拉尼比祖马布结合的二甲酸盐有效地减少了DME的静脉内注射频率.
- 与拉尼比祖马布单独治疗相比,这种组合疗法在BCVA和CMT方面提供了卓越的改善.
- 联合治疗显示出良好的安全性概况,并且耐受性良好.
相关概念视频
Dosage Regimen: Fixed Dose
2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.9K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.9K
Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55


